吡咯喹啉醌 (PQQ) Pyrroloquinoline Quinone (PQQ)

INT-pyrroloquinoline-quinone-001 3 個適應症被研究
C 2 U 1

適應症與證據等級

法規與權威立場 (L4)

L4a · US FDA
立場:supportive
FDA has no questions at this time regarding [the notifier's] conclusion that pyrroloquinoline quinone (PQQ) disodium salt is GRAS under the intended conditions of use.
來源 ↗
L4b · EU EFSA
立場:neutral
The Panel concludes that the NF, pyrroloquinoline quinone disodium salt (BioPQQ™), is safe under the intended conditions of use as specified by the applicant.
來源 ↗
L4c · UK NHS
立場:not_addressed
Food Supplements as defined in Directive 2002/46/EC intended for the adult population, excluding pregnant and lactating women. ... This food supplement should be consumed by adults only excluding pregnant and lactating women.
來源 ↗
L4d · TW TFDA / 衛福部
立場:cautious
L4e · WHO
立場:supportive
Pyrroloquinoline quinone disodium salt produced by fermentation using Hyphomicrobium denitrificans CK-275 is safe under the intended conditions of use. The applicant intends to market PQQ for use in food supplements for healthy adults, except pregnant and lactating women, at a maximum proposed level of consumption of 20 mg/day (corresponding to 0.29 mg/kg bw per day for a 70-kg person).
來源 ↗

市場與行銷 (L10)

L10a · TW Market Channels
California Gold PQQ 20mg 60粒 $473
L10b · TW Legal Identity (TFDA)
食品不得宣稱醫療效能
L10c · TW Community (PTT/Dcard/Mobile01)